Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic efficacy evaluation of artemether + lumefantrine in children with uncomplicated falciparum malaria in Sierra Leone
PACTR202604530789647Phase 4Not yet recruiting
- Sponsor
- Department of States
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in malaria and Falciparum malaria (PF), sponsored by Department of States. Primary endpoints: Adequate Clinical and Parasitological Response at Day 28, Early Treatment Failure and 2 more. Planned start May 2026; status: not yet recruiting.
02
Drugs
artemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on PACTR202604530789647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202604530789647.